Moshe Arkin - Net Worth and Insider Trading
Moshe Arkin Net Worth
The estimated net worth of Moshe Arkin is at least $2,443 dollars as of 2025-04-28. Moshe Arkin is the of Orexigen Therapeutics Inc and owns about 460,964 shares of Orexigen Therapeutics Inc (OREXQ) stock worth over $2,443. Details can be seen in Moshe Arkin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Moshe Arkin has not made any transactions after 2010-07-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Moshe Arkin
Moshe Arkin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Moshe Arkin owns 4 companies in total, including Keros Therapeutics Inc (KROS) , NeurogesX Inc (NGSX) , and Orexigen Therapeutics Inc (OREXQ) among others .
Click here to see the complete history of Moshe Arkin’s form 4 insider trades.
Insider Ownership Summary of Moshe Arkin
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| KROS | Keros Therapeutics Inc | 2020-04-07 | 10 percent owner |
| NGSX | NeurogesX Inc | 2011-08-09 | 10 percent owner & other: also member of 10% owner group |
| OREXQ | Orexigen Therapeutics Inc | 2010-07-15 | other: member of 10% owner group |
 | | 2021-04-29 | 10 percent owner |
Moshe Arkin Latest Holdings Summary
Moshe Arkin currently owns a total of 1 stock. Moshe Arkin owns 460,964 shares of Orexigen Therapeutics Inc (OREXQ) as of July 15, 2010, with a value of $2,443.
Latest Holdings of Moshe Arkin
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OREXQ | Orexigen Therapeutics Inc | 2010-07-15 | 460,964 | 0.01 | 2,443 |
Holding Weightings of Moshe Arkin
Moshe Arkin Form 4 Trading Tracker
According to the SEC Form 4 filings, Moshe Arkin has made a total of 0 transactions in Orexigen Therapeutics Inc (OREXQ) over the past 5 years. The most-recent trade in Orexigen Therapeutics Inc is the sale of 10,500 shares on July 15, 2010, which brought Moshe Arkin around $592,200.
Insider Trading History of Moshe Arkin
- 1
Moshe Arkin Trading Performance
Moshe Arkin Ownership Network
Ownership Network List of Moshe Arkin
Ownership Network Relation of Moshe Arkin
Moshe Arkin Owned Company Details
What does Keros Therapeutics Inc do?
Who are the key executives at Keros Therapeutics Inc?
Moshe Arkin is the 10 percent owner of Keros Therapeutics Inc. Other key executives at Keros Therapeutics Inc include Chief Financial Officer Keith Regnante , Chief Scientific Officer Jennifer Lachey , and Chief Operating Officer Christopher Rovaldi .
Keros Therapeutics Inc (KROS) Insider Trades Summary
Over the past 18 months, Moshe Arkin made no insider transaction in Keros Therapeutics Inc (KROS). Other recent insider transactions involving Keros Therapeutics Inc (KROS) include a net sale of 80,000 shares made by Keith Regnante , a net purchase of 934,258 shares made by , and a net sale of 250,000 shares made by Carl L Gordon .
In summary, during the past 3 months, insiders sold 0 shares of Keros Therapeutics Inc (KROS) in total and bought 934,258 shares, with a net purchase of 934,258 shares. During the past 18 months, 580,000 shares of Keros Therapeutics Inc (KROS) were sold and 934,258 shares were bought by its insiders, resulting in a net purchase of 354,258 shares.
Keros Therapeutics Inc (KROS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Keros Therapeutics Inc Insider Transactions
Moshe Arkin Mailing Address
Above is the net worth, insider trading, and ownership report for Moshe Arkin. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Moshe Arkin's mailing address is: Herzelia L3 4672406.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
